Anthony Letai was Named as the New Director of NIH’s National Cancer Institute

The National Cancer Institute at the NIH has welcomed Dr. Anthony Letai as its new director. Dr. Letai brings extensive experience in cancer research, focusing on cell death mechanisms, predictive biomarker identification, and the development of novel treatments, particularly cellular immunotherapies.

About the role

Dr. Letai will lead the nation's leading cancer research agency, committed to reducing the prevalence of cancer and contributing to the overall goal of making America healthy again.